These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34577546)

  • 1. Preparation of Solid Dispersions of Simvastatin and Soluplus Using a Single-Step Organic Solvent-Free Supercritical Fluid Process for the Drug Solubility and Dissolution Rate Enhancement.
    Nandi U; Ajiboye AL; Patel P; Douroumis D; Trivedi V
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations.
    Zhang Y; Liu Y; Luo Y; Yao Q; Zhong Y; Tian B; Tang X
    Drug Deliv; 2016 Jul; 23(6):1902-11. PubMed ID: 25268150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation.
    Pandya P; Gattani S; Jain P; Khirwal L; Surana S
    AAPS PharmSciTech; 2008; 9(4):1247-52. PubMed ID: 19115110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
    Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
    Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques.
    Obaidat RM; Khanfar M; Ghanma R
    AAPS PharmSciTech; 2019 May; 20(5):194. PubMed ID: 31119496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Spray-Drying and Co-Precipitation for the Generation of Amorphous Solid Dispersions (ASDs) of Hydrochlorothiazide and Simvastatin.
    Myślińska M; Stocker MW; Ferguson S; Healy AM
    J Pharm Sci; 2023 Aug; 112(8):2097-2114. PubMed ID: 36805392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations.
    Ambike AA; Mahadik KR; Paradkar A
    Pharm Res; 2005 Jun; 22(6):990-8. PubMed ID: 15948043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions.
    Jia S; Ning S; Leng Y; Jing Q; Xu Z; Ren F
    Polymers (Basel); 2022 Mar; 14(6):. PubMed ID: 35335571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.
    Liu C; Liu C; Desai KG
    Drug Dev Ind Pharm; 2005 Jan; 31(1):1-10. PubMed ID: 15704852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved physicochemical characteristics of artemisinin-nicotinamide solid dispersions by solvent evaporation and freeze dried methods.
    Ansari MT; Pervez H; Shehzad MT; Mahmood Z; Razi MT; Ranjha NM; Khanum N
    Pak J Pharm Sci; 2012 Apr; 25(2):447-56. PubMed ID: 22459476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded soluplus® based ternary solid dispersions with enhanced solubility, dissolution and antibacterial, antioxidant, anti-inflammatory activities.
    Ishtiaq M; Manzoor H; Khan IU; Asghar S; Irfan M; Albekairi NA; Alshammari A; Alqahtani AF; Alotaibi S; Munir R; Shah PA; Hussain L; Saleem MA; Razzaq FA; Khalid SH
    Heliyon; 2024 Jul; 10(14):e34636. PubMed ID: 39130422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High energy ball milling and supercritical carbon dioxide impregnation as co-processing methods to improve dissolution of tadalafil.
    Krupa A; Descamps M; Willart JF; Jachowicz R; Danède F
    Eur J Pharm Sci; 2016 Dec; 95():130-137. PubMed ID: 27167825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical fluid technology.
    Liu H; Zhou LL; Wei LL; Hong-Guo ; Nie SF; Yang XG; Tang R; Pan WS
    Drug Dev Ind Pharm; 2007 Sep; 33(9):959-66. PubMed ID: 17891582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.